Grifols has signed a strategic agreement with Inpeco to provide transfusion medicine labs with complete, tailored ...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

Grifols announced on Thursday that it has signed a strategic agreement with Swiss laboratory automation firm Inpeco to provide automated instrumentation, robotics, and software to transfusion medicine ...

Grifols (GRFS) issued a statement to address certain information published in a media outlet on March 8, specifically a front-page article ...

In this article, we are going to take a look at where Grifols, S.A. (NASDAQ:GRFS) stands against the other pharma stocks. Healthcare, which includes numerous businesses that offer patient care ...

Muddy Waters CEO Carson Block picked Grifols (GRFS) as a short for the Robin Hood Foundation’s stock picking contest. However, said in an ...

It's time for an update on the Medical company Grifols, S.A. (NASDAQ:GRFS). It's been about 4 months since I last updated on the business, with that update being specific to an event where ...

Spanish plasma-derived medicines specialist Grifols (MCE: GRF) has announced positive results from its Phase II/III clinical ...

In this article, we are going to take a look at where Grifols, S.A. (NASDAQ:GRFS) stands against the other pharma stocks. The Rising Demand for Weight-Loss Medications and GLP-1 Developments ...

The net impact on the market is typically positive. Take Gotham City Research LLC’s dramatic assault on Grifols SA in January last year. The US hedge fund’s diatribe against the Spanish ...